<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40"><head><meta http-equiv=Content-Type content="text/html; charset=us-ascii"><meta name=Generator content="Microsoft Word 12 (filtered medium)"><style><!--
/* Font Definitions */
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0in;
margin-bottom:.0001pt;
font-size:11.0pt;
font-family:"Calibri","sans-serif";}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:blue;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:purple;
text-decoration:underline;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
{mso-style-priority:34;
margin-top:0in;
margin-right:0in;
margin-bottom:0in;
margin-left:.5in;
margin-bottom:.0001pt;
font-size:11.0pt;
font-family:"Calibri","sans-serif";}
span.EmailStyle17
{mso-style-type:personal-compose;
font-family:"Arial","sans-serif";
color:windowtext;}
.MsoChpDefault
{mso-style-type:export-only;}
@page WordSection1
{size:8.5in 11.0in;
margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection1
{page:WordSection1;}
/* List Definitions */
@list l0
{mso-list-id:1103455226;
mso-list-type:hybrid;
mso-list-template-ids:-1979039282 67698689 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l0:level1
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:none;
mso-level-number-position:left;
margin-left:39.0pt;
text-indent:-.25in;
font-family:Symbol;}
@list l0:level2
{mso-level-tab-stop:1.0in;
mso-level-number-position:left;
text-indent:-.25in;}
@list l0:level3
{mso-level-tab-stop:1.5in;
mso-level-number-position:left;
text-indent:-.25in;}
@list l0:level4
{mso-level-tab-stop:2.0in;
mso-level-number-position:left;
text-indent:-.25in;}
@list l0:level5
{mso-level-tab-stop:2.5in;
mso-level-number-position:left;
text-indent:-.25in;}
@list l0:level6
{mso-level-tab-stop:3.0in;
mso-level-number-position:left;
text-indent:-.25in;}
@list l0:level7
{mso-level-tab-stop:3.5in;
mso-level-number-position:left;
text-indent:-.25in;}
@list l0:level8
{mso-level-tab-stop:4.0in;
mso-level-number-position:left;
text-indent:-.25in;}
@list l0:level9
{mso-level-tab-stop:4.5in;
mso-level-number-position:left;
text-indent:-.25in;}
ol
{margin-bottom:0in;}
ul
{margin-bottom:0in;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]--></head><body lang=EN-US link=blue vlink=purple><div class=WordSection1><p class=MsoNormal>Dear Business Managers, Superintendents & Benefits Administrators:<o:p></o:p></p><p class=MsoNormal><o:p> </o:p></p><p class=MsoNormal>Attached are two letters ODS plans to mail to affected OEBB members tomorrow. <o:p></o:p></p><p class=MsoNormal><o:p> </o:p></p><p class=MsoNormal>ODS regularly reviews and updates their prescription formularies according to the following schedule:<o:p></o:p></p><p class=MsoNormal><o:p> </o:p></p><p class=MsoListParagraph style='mso-margin-top-alt:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:38.9pt;text-indent:-.25in;mso-list:l0 level1 lfo1'><![if !supportLists]><span style='font-family:Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'> </span></span></span><![endif]>Formulary tiering changes on a semi-annual basis -- January and July; and <o:p></o:p></p><p class=MsoListParagraph style='margin-left:39.0pt;text-indent:-.25in;mso-list:l0 level1 lfo1'><![if !supportLists]><span style='font-family:Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'> </span></span></span><![endif]>Utilization management (prior authorization, quantity limits, gender restrictions, step therapy, age restrictions) updates on a quarterly basis, January, April, July and October.<o:p></o:p></p><p class=MsoNormal><span style='font-size:12.0pt;font-family:"Arial","sans-serif"'><o:p> </o:p></span></p><p class=MsoNormal>The attached letters provide approximately six weeks notice to those members who will be affected by the January 2012 formulary updates.<o:p></o:p></p><p class=MsoNormal><o:p> </o:p></p><p class=MsoNormal>ODS provided the following information you may find helpful when assisting affected employees who contact you: <o:p></o:p></p><p class=MsoNormal><i><o:p> </o:p></i></p><p class=MsoNormal style='mso-margin-top-alt:0in;margin-right:.5in;margin-bottom:0in;margin-left:.5in;margin-bottom:.0001pt'><i>The bulk of the members affected by the change will be members who have a claim for Crestor, which will be transitioning from tier 2 to tier 3. Crestor has multiple alternatives that have been found to be therapeutically effective for the majority of the population, while also being much more cost effective. There are also two alternatives to Crestor that are available under the Value Tier benefits.<o:p></o:p></i></p><p class=MsoNormal><span style='color:#1F497D'><o:p> </o:p></span></p><p class=MsoNormal>If you have any questions please let me know. You may also encourage employees who come to you with questions about the formulary change to call the ODS Pharmacy Team at 866-923-0411. <o:p></o:p></p><p class=MsoNormal><o:p> </o:p></p><p class=MsoNormal>Thank you.<span style='font-family:"Arial","sans-serif"'><o:p></o:p></span></p><p class=MsoNormal><span style='font-family:"Arial","sans-serif"'><o:p> </o:p></span></p><p class=MsoNormal><b><span style='color:navy'>Jackie Cowsill</span></b><o:p></o:p></p><p class=MsoNormal><span style='font-size:10.0pt;color:navy'>Communications Coordinator</span><o:p></o:p></p><p class=MsoNormal><span style='font-size:10.0pt;color:navy'>Oregon Educators Benefit Board</span><o:p></o:p></p><p class=MsoNormal><span style='font-size:10.0pt;color:navy'>Voice: (503) 378-5353</span><o:p></o:p></p><p class=MsoNormal><span style='font-size:10.0pt;color:navy'>Fax: (503) 378-5832</span><o:p></o:p></p><p class=MsoNormal><o:p> </o:p></p></div></body></html>